Sign In
News Digest /
Ticker: ALUR
Ticker: ALUR
10:18am, Tuesday, Nov 11, 2025
Allurion Technologies (NYSE:ALUR) shares jump over 10% following key FDA pre-market approval milestones and a debt-for-equity exchange plan aimed at eliminating debt burden.
05:05pm, Thursday, Aug 28, 2025
Snapshot - Allurion Technologies, Inc. (NYSE: ALUR)
Straight to the point: Allurion has restated its Q1 2024 results after discovering a material error tied to weaknesses in accounting controls. The company shows a small GAAP net income for Q1 2024 driven largely by non‑cash fair‑value gains on ...
05:03pm, Thursday, Aug 28, 2025
Allurion Technologies, Inc. (NYSE: ALUR)
Quick take - straight to the point: the company is in active remediation and refinancing mode. It restated Q2 2024 results because of control failures, completed a 1-for-25 reverse split, replaced a term loan with convertible notes from RTW, and is dealing...
05:02pm, Thursday, Aug 28, 2025
Snapshot - Allurion Technologies, Inc. (NYSE: ALUR)
Allurion just filed an amended Q3 2024 10‑Q/A: it restated Q3 (and other prior) results after finding booking errors tied to internal control weaknesses, completed a 1‑for‑25 reverse split, drove a large fair‑value swing that produced a GAAP Q3 ...
06:13pm, Tuesday, Aug 19, 2025
Company: Allurion Technologies, Inc. (NYSE: ALUR) - quick take: the business is shrinking top line, operating losses remain significant, management has restated prior-period results and disclosed material weaknesses, and the company is executing a major restructuring while pursuing FDA PMA comple...
05:02pm, Tuesday, Aug 19, 2025
Allurion Technologies, Inc. (ALUR) - Quick corporate snapshot & what's happening inside
Headline
* The company restated its Q1 2025 and Q1 2024 results due to an error in measurement of fair‑value changes and OCI; management attributes this to material weaknesses in internal controls and insuffic...